411 related articles for article (PubMed ID: 28348555)
1. A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.
Polycarpou A; Walker SL; Lockwood DN
Front Immunol; 2017; 8():233. PubMed ID: 28348555
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN
Front Immunol; 2018; 9():189. PubMed ID: 29479352
[TBL] [Abstract][Full Text] [Related]
3. T-cell regulation in Erythema Nodosum Leprosum.
Negera E; Walker SL; Bobosha K; Howe R; Aseffa A; Dockrell HM; Lockwood DN
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006001. PubMed ID: 28991896
[TBL] [Abstract][Full Text] [Related]
4. Towards understanding the pathology of erythema nodosum leprosum.
Kahawita IP; Lockwood DN
Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):329-37. PubMed ID: 18313706
[TBL] [Abstract][Full Text] [Related]
5.
Tavares IF; Dos Santos JB; Pacheco FDS; Gandini M; Mariante RM; Rodrigues TF; Sales AM; Moraes MO; Sarno EN; Schmitz V
Front Med (Lausanne); 2021; 8():711623. PubMed ID: 34692720
[TBL] [Abstract][Full Text] [Related]
6. New Insight into the Pathogenesis of Erythema Nodosum Leprosum: The Role of Activated Memory T-Cells.
Negera E; Bobosha K; Walker SL; Endale B; Howe R; Aseffa A; Dockrell HM; Lockwood DN
Front Immunol; 2017; 8():1149. PubMed ID: 28966621
[TBL] [Abstract][Full Text] [Related]
7. ENLIST 1: An International Multi-centre Cross-sectional Study of the Clinical Features of Erythema Nodosum Leprosum.
Walker SL; Balagon M; Darlong J; Doni SN; Hagge DA; Halwai V; John A; Lambert SM; Maghanoy A; Nery JA; Neupane KD; Nicholls PG; Pai VV; Parajuli P; Sales AM; Sarno E; Shah M; Tsegaye D; Lockwood DN;
PLoS Negl Trop Dis; 2015; 9(9):e0004065. PubMed ID: 26351858
[TBL] [Abstract][Full Text] [Related]
8. Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient.
Moraes MO; Sampaio EP; Nery JA; Saraiva BC; Alvarenga FB; Sarno EN
Br J Dermatol; 2001 Jan; 144(1):175-81. PubMed ID: 11167702
[TBL] [Abstract][Full Text] [Related]
9. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
[TBL] [Abstract][Full Text] [Related]
10. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
11. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
[TBL] [Abstract][Full Text] [Related]
12. Image Morphometric Analysis of B Cells and Plasma Cells in Erythema Nodosum Leprosum With Clinicopathological Correlation.
Biswas D; Sethy M; Behera B; Palit A; Mitra S
Am J Dermatopathol; 2021 Oct; 43(10):700-706. PubMed ID: 33264135
[TBL] [Abstract][Full Text] [Related]
13. Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin.
Gupta N; Shankernarayan NP; Dharmalingam K
J Proteome Res; 2007 Sep; 6(9):3669-79. PubMed ID: 17658739
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils in Leprosy.
Schmitz V; Tavares IF; Pignataro P; Machado AM; Pacheco FDS; Dos Santos JB; da Silva CO; Sarno EN
Front Immunol; 2019; 10():495. PubMed ID: 30949168
[TBL] [Abstract][Full Text] [Related]
15. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum.
Modlin RL; Mehra V; Jordan R; Bloom BR; Rea TH
J Immunol; 1986 Feb; 136(3):883-6. PubMed ID: 2416837
[TBL] [Abstract][Full Text] [Related]
16. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
Foss NT; de Oliveira EB; Silva CL
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
[TBL] [Abstract][Full Text] [Related]
17. [Review: update on erythema nodosum leprosum].
Morand JJ; Badiane C; Bobin P
Med Trop (Mars); 2004; 64(5):423-30. PubMed ID: 15771008
[TBL] [Abstract][Full Text] [Related]
18. Increased serum levels of interleukin-6 in erythema nodosum leprosum suggest its use as a biomarker.
Vilani-Moreno FR; Brito-de-Souza VN; Silva SMUR; Barbosa ASAA; Sartori BGC; Campanelli AP; Barreto JA; Virmond MDCL
Indian J Dermatol Venereol Leprol; 2021; 87(2):190-198. PubMed ID: 33769734
[TBL] [Abstract][Full Text] [Related]
19. A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction.
Voorend CG; Post EB
PLoS Negl Trop Dis; 2013; 7(10):e2440. PubMed ID: 24098819
[TBL] [Abstract][Full Text] [Related]
20. Complement C1q expression in Erythema nodosum leprosum.
Negera E; Walker SL; Lema T; Aseffa A; Lockwood DN; Dockrell HM
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006321. PubMed ID: 29499046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
